- Home
- AZN
AZN
AstraZeneca PLC
as 12-20-2024 4:00pm EST
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
| Founded: | 1992 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 212.2B | IPO Year: | 1993 |
| Target Price: | $88.80 | AVG Volume (30 days): | 5.4M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 4.15 | EPS Growth: | 9.79 |
| 52 Week Low/High: | $60.47 - $87.68 | Next Earning Date: | 02-06-2025 |
| Revenue: | $51,206,000,000 | Revenue Growth: | 13.81% |
| Revenue Growth (this year): | 17.69% | Revenue Growth (next year): | 7.95% |
Latest AstraZeneca PLC News
AZN Breaking Stock News: Dive into AZN Ticker-Specific Updates for Smart Investing
Zacks
16 hours ago
Why Astrazeneca (AZN) Outpaced the Stock Market Today
Fortune
18 hours ago
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
Zacks
a day ago
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks
3 days ago
Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance
MT Newswires
3 days ago
Astrazeneca's Alexion Pharma Signs LOI With Pan-Canadian Pharmaceutical Alliance for Koselugo
CNW Group
3 days ago
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
MT Newswires
3 days ago
Market Chatter: AstraZeneca's Sales in China Hit by Arrest of Country Head, Oncology Products Affected
Insider Monkey
4 days ago
Is AstraZeneca PLC (AZN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Compare AZN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AZN AstraZeneca PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.